99216-67-8

Basic information

• Product Name: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-
• Synonyms: (1R,2R)-(2-Hydroxy-1-hydroxymethyl-propyl)-carbamic acid tert-butyl ester;tert-Butyl ((2R,3R)-1,3-dihydroxybutan-2-yl)carbamate;Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-;N-BOC-L-THREONOL
• CAS NO: 99216-67-8
• Molecular Formula: C₉H₁₉NO₄
• Molecular Weight: 205.25146
• Product Categories: N-BOC
• Mol File: 99216-67-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 366.8°C at 760 mmHg
• Flash Point: 175.6°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 7.22E-07mmHg at 25°C
• Refractive Index: 1.474
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-(99216-67-8)
• EPA Substance Registry System: Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-(99216-67-8)

Safety Data

• Hazardous Substances Data: 99216-67-8(Hazardous Substances Data)

Usage

General Description

Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1- is an organic compound with the molecular formula C5H11NO4. It is a carbamic acid derivative with a 1,1 configuration, meaning that the hydroxy and hydroxymethyl groups are positioned in a specific arrangement on the carbon atoms. Carbamic acid, [(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, 1,1- is commonly used as a precursor in the synthesis of various pharmaceuticals and agrochemicals. It is also used in the production of carbamate pesticides and in the synthesis of carbamic acid esters. Additionally, it has potential applications in the fields of medicine and biotechnology due to its unique chemical structure and properties.

InChI:InChI=1/C9H19NO4/c1-6(12)7(5-11)10-8(13)14-9(2,3)4/h6-7,11-12H,5H2,1-4H3,(H,10,13)/t6-,7-/m1/s1

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 2592-18-9 Boc-Thr-OH 
• 98015-52-2 1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate 
• 3228-51-1 L-threoninol 
• 60538-19-4 N-(tert-butoxycarbonyl)-l-threonine methyl ester 
• 41840-28-2 S-tert-butoxycarbonyl-4,6-dimethyl-2-mercaptopyrimidine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 873000-89-6 benzoic acid 2-tert-butoxycarbonylamino-3-oxo-butyl ester 
• 873000-92-1 (2R,3R)-2-Benzoyloxymethyl-3-methyl-3-triethylsilanyloxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 144634-11-7 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,3,4-trideoxy-2-(tert-butoxycarbonylamino)-D-threo-L-galacto-deconic acid 
• 167102-63-8 (R)-N,O-isopropylidenyl-4-(N-tert-butyloxycarbonylamino)-3-oxo-2-butanone 
• 204187-64-4 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,3,4-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-threo-L-galacto-decitol 
• 213820-05-4 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,3,4-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-threo-L-gulo-decitol 
• 213819-86-4 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,3,4-trideoxy-2-(tert-butoxycarbonylamino)-D-threo-L-gulo-deconic acid 
• 213820-07-6 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,4-dideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-threo-L-galacto-3-deculose 
• 213820-02-1 5,9-anhydro-6,7,8,10-tetra-O-benzyl-2,4-dideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-threo-L-gulo-3-deculose 
• 213828-86-5 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,3,4,5-tetradeoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-erythro-L-galacto-undecitol 
• 213828-83-2 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,3,4,5-tetradeoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-threo-L-galacto-undecitol 
• 220542-60-9 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,4,5-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-arabino-D-manno/D-altro-undecitol 
• 220542-58-5 6,10-anhydro-7,8,9,11-tetra-O-benzyl-2,4,5-trideoxy-1,2-N,O-isopropylidene-2-(tert-butoxycarbonylamino)-D-lyxo-D-manno/D-altro-undecitol 

Relevant articles and documents

Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2′s-hydroxy-3′s-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors

A series of terminal nonyl chain and nucleobase modified analogues of (+)-EHNA (III) were synthesized and evaluated for their ability to inhibit adenosine deaminase (ADA). The constrained carbon analogues of (+)-EHNA, 7a-7h, 10a-c, 12, 13, 14 and 17a-c appeared very potent with Ki values in the low nanomolar range. Thio-analogues of (+)-EHNA 24a-e wherein 5′C of nonyl chain replaced by sulfur atom found to be less potent compared to (+)-EHNA. Docking of the representative compounds into the active site of ADA was performed to understand structure-activity relationships. Compounds 7a (Ki: 1.1 nM) 7b (Ki: 5.2 nM) and 26a (Ki: 5.9 nM) showed suitable balance of potency, microsomal stability and demonstrated better pharmacokinetic properties as compared to (+)-EHNA and therefore may have therapeutic potential for various inflammatory diseases, hypertension and cancer.

IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS

The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which is useful in the treatment of a tumor through its ROS1 kinase enzyme activity inhibitory effect and NTRK kinase enzyme inhibitory effect. The present invention provides a compound having an imidazo[1,2-b]pyridazine structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, G, T, Y1, Y2, Y3, and Y4 are as defined herein.

Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464

FR901464, a natural product isolated from a bacterium source, activates a reporter gene, inhibits pre-mRNA splicing, and shows antitumor activity. We previously reported the development of a more potent analogue, meayamycin, through the total synthesis of